BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
21 results:

  • 1. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and safety of laparoscopic liver resection for hepatocellular carcinoma in segment 8: a propensity score-matched two-center study.
    Yamasaki N; Gon H; Yamane H; Yoshida T; Soyama H; Kido M; Tanaka M; Komatsu S; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
    Surg Endosc; 2023 Nov; 37(11):8438-8446. PubMed ID: 37464067
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The prognosis of elderly patients with hepatocellular carcinoma after curative hepatectomy a multicenter competing risk analysis.
    Lu Y; Liang L; Lu WF; Cheng J; Yao WF; Xie YM; Wang DD; Xu FQ; Xiao ZQ; Zhang JG; Liu JW; Zhang CW; Huang DS
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102147. PubMed ID: 37245639
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinoma.
    Ma J; Song Y; Zhuang T; Yang H; Yang X; Zheng J; Luo J; Xia Y; Fei X; Chan DW; Wu D; Xu P; Ni P; Dai J; Xu D; Hu Y
    Front Immunol; 2023; 14():1158964. PubMed ID: 37187730
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immune profiling and prognostic model of pancreatic cancer using quantitative pathology and single-cell RNA sequencing.
    Chen K; Wang Q; Liu X; Tian X; Dong A; Yang Y
    J Transl Med; 2023 Mar; 21(1):210. PubMed ID: 36944944
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Anticancer Benefit of Metformin in Patients With Early-Stage pancreatic cancer: A Retrospective Cohort Study.
    Chen Y; Qian FJ; Ye ZQ; Xie WX; He YD; Huang JR; Tian L; Gu DN
    Technol Cancer Res Treat; 2022; 21():15330338221138208. PubMed ID: 36583563
    [No Abstract]    [Full Text] [Related]  

  • 7. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From pancreatic cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation.
    Zhao C; Ma B; Yang ZY; Li O; Liu SL; Pan LJ; Gong W; Dong P; Shu YJ
    Cancer Med; 2023 Mar; 12(5):5751-5763. PubMed ID: 36200270
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mihc and spatial distribution analysis.
    Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
    Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric cancer After Neoadjuvant Chemotherapy.
    Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM
    JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]    [Full Text] [Related]  

  • 13. High expression of
    Xu JZ; Jiang JJ; Xu HJ; Sun XD; Liu ZC; Hu ZM
    Scand J Gastroenterol; 2021 Nov; 56(11):1349-1354. PubMed ID: 34396876
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification and Validation of Immune Molecular Subtypes in pancreatic Ductal Adenocarcinoma: Implications for prognosis and Immunotherapy.
    Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
    Front Immunol; 2021; 12():690056. PubMed ID: 34335594
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
    An L; Yin WT; Sun DW
    BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma.
    Abdel-Rahman O; Spratlin J; Koski S
    Med Oncol; 2021 Feb; 38(2):18. PubMed ID: 33534008
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Three Distinct Stroma Types in Human pancreatic cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen.
    Ogawa Y; Masugi Y; Abe T; Yamazaki K; Ueno A; Fujii-Nishimura Y; Hori S; Yagi H; Abe Y; Kitago M; Sakamoto M
    Clin Cancer Res; 2021 Jan; 27(1):107-119. PubMed ID: 33046515
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis.
    Xu S; Lei SL; Liu KJ; Yi SG; Yang ZL; Yao HL
    Cancer Gene Ther; 2021 Apr; 28(3-4):234-249. PubMed ID: 32855541
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Treatment Strategy for Borderline Resectable pancreatic cancer With Radiographic Artery Involvement.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
    Pancreas; 2016 Nov; 45(10):1438-1446. PubMed ID: 27088490
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.